Literature DB >> 8800796

Patients infected with high-hazard viruses: scientific basis for infection control.

C J Peters1, P B Jahrling, A S Khan.   

Abstract

Most of the viral hemorrhagic fevers (VHFs) are caused by viruses that are handled in high containment laboratories in Europe and the United States because of their high pathogenicity and their aerosol infectivity. Special precautions should be taken when caring for patients infected with these viruses, but most hospitals can safely provide high-quality care. The major danger is parenteral inoculation of a staff member. Fomites and droplets must be considered as well. The role of small particle aerosols in inter-human transmission continues to be controversial. We believe that the aerosol infectivity observed for these viruses in the laboratory and the rare clinical situations that suggest aerosol spread dictate caution, but the many instances in which no transmission occurs provide a framework in which a measured approach is possible. The major challenge is in early recognition by an educated medical staff and rapid specific etiological diagnosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800796     DOI: 10.1007/978-3-7091-7482-1_13

Source DB:  PubMed          Journal:  Arch Virol Suppl        ISSN: 0939-1983


  11 in total

1.  Research gaps in protecting healthcare workers from SARS and other respiratory pathogens: an interdisciplinary, multi-stakeholder, evidence-based approach.

Authors:  Annalee Yassi; David Moore; J Mark Fitzgerald; Philip Bigelow; Chun-Yip Hon; Elizabeth Bryce
Journal:  J Occup Environ Med       Date:  2005-01       Impact factor: 2.162

2.  Severe Rift Valley fever may present with a characteristic clinical syndrome.

Authors:  Summerpal S Kahlon; Clarence J Peters; James Leduc; Eric M Muchiri; Samuel Muiruri; M Kariuki Njenga; Robert F Breiman; A Clinton White; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

3.  Clusters of hantavirus infection, southern Argentina.

Authors:  Maria E Lázaro; Gustavo E Cantoni; Liliana M Calanni; Amanda J Resa; Eduardo R Herrero; Marisa A Iacono; Delia A Enria; Stella M González Cappa
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

4.  The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola.

Authors:  Allen Grolla; Steven M Jones; Lisa Fernando; James E Strong; Ute Ströher; Peggy Möller; Janusz T Paweska; Felicity Burt; Pedro Pablo Palma; Armand Sprecher; Pierre Formenty; Cathy Roth; Heinz Feldmann
Journal:  PLoS Negl Trop Dis       Date:  2011-05-24

5.  Comparative study between Ribavirin and Ribavirin plus Intravenous Immunoglobulin against Crimean Congo hemorrhagic fever.

Authors:  Hassan Salehi; Marzieh Salehi; Neda Adibi; Maryam Salehi
Journal:  J Res Med Sci       Date:  2013-06       Impact factor: 1.852

Review 6.  The Political Economy of the Ebola Virus Disease (EVD); Taking Individual and Community Ownership in the Prevention and Control of EVD.

Authors:  Titilola T Obilade
Journal:  Healthcare (Basel)       Date:  2015-01-28

7.  Rapid deployment of a mobile biosafety level-3 laboratory in Sierra Leone during the 2014 Ebola virus epidemic.

Authors:  Yi Zhang; Yan Gong; Chengyu Wang; Wensen Liu; Zhongyi Wang; Zhiping Xia; Zhaoyang Bu; Huijun Lu; Yang Sun; Xiaoguang Zhang; Yuxi Cao; Fan Yang; Haoxiang Su; Yi Hu; Yongqiang Deng; Bo Zhou; Zongzheng Zhao; Yingying Fu; David Kargbo; Foday Dafae; Brima Kargbo; Alex Kanu; Linna Liu; Jun Qian; Zhendong Guo
Journal:  PLoS Negl Trop Dis       Date:  2017-05-15

Review 8.  Clinical Management of Patients with Ebola Virus Disease in High-Resource Settings.

Authors:  G Marshall Lyon; Aneesh K Mehta; Bruce S Ribner
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

9.  Lookback exercise with imported Crimean-Congo hemorrhagic fever, Senegal and France.

Authors:  Arnaud Tarantola; Pierre Nabeth; Pierre Tattevin; Christian Michelet; Hervé Zeller
Journal:  Emerg Infect Dis       Date:  2006-09       Impact factor: 6.883

10.  Characterization of anti-BCG benz[α]anthraquinones and new siderophores from a Xinjiang desert-isolated rare actinomycete Nocardia sp. XJ31.

Authors:  Li Zhang; Jingyu Zhang; Biao Ren; Wanying Lu; Chengjian Hou; Jian Wang; Xiaolong Ma; Rong Ma; Mei Liu; Zhiheng Liu; Jin-Ping Li; Kan Ding; Huanqin Dai; Lixin Zhang; Xueting Liu
Journal:  Appl Microbiol Biotechnol       Date:  2020-08-24       Impact factor: 5.560

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.